ALAFI MOSHE

CIK 00010088903 companiesEMERYVILLE, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001008890

Recent Transactions

26 trades

Purchase
Intra-Cellular Therapies, Inc.
Common Stock
2017-10-02$15.50/sh+258,065→ 3,953,270 total
Purchase
Intra-Cellular Therapies, Inc.
Common Stock
2016-12-07$16.14/sh+20,826→ 3,695,205 total
Purchase
Intra-Cellular Therapies, Inc.
Common Stock
2016-12-06$16.33/sh+44,174→ 3,674,379 total
Purchase
Intra-Cellular Therapies, Inc.
Common Stock
2016-11-14$14.50/sh+34,000→ 3,630,205 total
Purchase
Intra-Cellular Therapies, Inc.
Common Stock
2014-12-01$14.75/sh+1,422→ 3,596,205 total
Purchase
Intra-Cellular Therapies, Inc.
Common Stock
2014-11-28$14.75/sh+35,000→ 3,594,783 total
Purchase
Intra-Cellular Therapies, Inc.
Common Stock
2014-11-19$14.25/sh+1,034→ 3,559,783 total
Purchase
Intra-Cellular Therapies, Inc.
Common Stock
2014-11-18$14.23/sh+3,531→ 3,558,749 total
Purchase
Intra-Cellular Therapies, Inc.
Common Stock
2014-11-14$15.07/sh+133→ 3,555,218 total
Purchase
Intra-Cellular Therapies, Inc.
Common Stock
2014-11-13$15.12/sh+2,200→ 3,555,085 total
Purchase
Intra-Cellular Therapies, Inc.
Common Stock
2014-11-12$15.23/sh+5,000→ 3,552,885 total
Purchase
Intra-Cellular Therapies, Inc.
Common Stock
2014-11-11$15.55/sh+5,000→ 3,547,885 total
Sale
Intra-Cellular Therapies, Inc.
Common Stock
2014-06-19$6.35/sh−15,742→ 0 total
Award
MOLECULAR DEVICES CORP
Stock Option (Right to Buy)
2005-05-26+4,000→ 4,000 total
Conversion
Stereotaxis, Inc.$STXS
Common Stock
2004-08-17+516,672→ 1,753,358 total
Conversion
Stereotaxis, Inc.$STXS
Series E-2 Convertible Preferred Stock
2004-08-17−819,113→ 0 total
Conversion
Stereotaxis, Inc.$STXS
Common Stock
2004-08-17+322,580→ 2,210,346 total
Conversion
Stereotaxis, Inc.$STXS
Series B Convertible Preferred Stock
2004-08-17−625,000→ 0 total
Conversion
Stereotaxis, Inc.$STXS
Common Stock
2004-08-17+675,571→ 849,182 total
Conversion
Stereotaxis, Inc.$STXS
Series D Convertible Preferred Stock
2004-08-17−1,382,488→ 0 total
Conversion
Stereotaxis, Inc.$STXS
Series D-1 Convertible Preferred Stock
2004-08-17−1,843,318→ 0 total
Conversion
Stereotaxis, Inc.$STXS
Series C Convertible Preferred Stock
2004-08-17−2,432,057→ 0 total
Conversion
Stereotaxis, Inc.$STXS
Common Stock
2004-08-17+134,408→ 1,887,766 total
Conversion
Stereotaxis, Inc.$STXS
Common Stock
2004-08-17+173,611→ 173,611 total
Conversion
Stereotaxis, Inc.$STXS
Common Stock
2004-08-17+387,504→ 1,236,686 total
Conversion
Stereotaxis, Inc.$STXS
Series D-2 Convertible Preferred Stock
2004-08-17−460,830→ 0 total

Companies

Recent Filings

Address

C/O ALAFI CAPITAL COMPANY, LLC 8 ADMIRAL DRIVE, SUITE 324

EMERYVILLE, CA, 94608

View on SEC.gov